Six-monthly monitoring of HbA1c may be too frequent for diabetes patients
Six-monthly monitoring of HbA1c among some patients with type 2 diabetes may be too frequent and cause unnecessary treatment changes, according to a study published by NHS Diabetes and Oxford University.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units